Csl Stock Net Income
| CSLLY Stock | USD 64.22 1.21 1.92% |
As of the 8th of February, CSL shows the Mean Deviation of 1.08, semi deviation of 1.3, and Risk Adjusted Performance of 0.1163. CSL technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
CSL's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing CSL's valuation are provided below:CSL does not now have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. CSL |
CSL 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CSL's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CSL.
| 11/10/2025 |
| 02/08/2026 |
If you would invest 0.00 in CSL on November 10, 2025 and sell it all today you would earn a total of 0.00 from holding CSL or generate 0.0% return on investment in CSL over 90 days. CSL is related to or competes with Sanofi, Siemens Healthineers, GSK Plc, Argenx SE, UCB SA, UCB SA, and Chugai Pharmaceutical. CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Austra... More
CSL Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CSL's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CSL upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.48 | |||
| Information Ratio | 0.0725 | |||
| Maximum Drawdown | 5.63 | |||
| Value At Risk | (2.06) | |||
| Potential Upside | 2.12 |
CSL Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CSL's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CSL's standard deviation. In reality, there are many statistical measures that can use CSL historical prices to predict the future CSL's volatility.| Risk Adjusted Performance | 0.1163 | |||
| Jensen Alpha | 0.1433 | |||
| Total Risk Alpha | 0.0443 | |||
| Sortino Ratio | 0.0657 | |||
| Treynor Ratio | 0.4199 |
CSL February 8, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1163 | |||
| Market Risk Adjusted Performance | 0.4299 | |||
| Mean Deviation | 1.08 | |||
| Semi Deviation | 1.3 | |||
| Downside Deviation | 1.48 | |||
| Coefficient Of Variation | 717.43 | |||
| Standard Deviation | 1.34 | |||
| Variance | 1.8 | |||
| Information Ratio | 0.0725 | |||
| Jensen Alpha | 0.1433 | |||
| Total Risk Alpha | 0.0443 | |||
| Sortino Ratio | 0.0657 | |||
| Treynor Ratio | 0.4199 | |||
| Maximum Drawdown | 5.63 | |||
| Value At Risk | (2.06) | |||
| Potential Upside | 2.12 | |||
| Downside Variance | 2.18 | |||
| Semi Variance | 1.68 | |||
| Expected Short fall | (1.07) | |||
| Skewness | (0.31) | |||
| Kurtosis | (0.51) |
CSL Backtested Returns
At this stage we consider CSL Pink Sheet to be very steady. CSL secures Sharpe Ratio (or Efficiency) of 0.12, which signifies that the company had a 0.12 % return per unit of return volatility over the last 3 months. We have found twenty-nine technical indicators for CSL, which you can use to evaluate the volatility of the firm. Please confirm CSL's Risk Adjusted Performance of 0.1163, mean deviation of 1.08, and Semi Deviation of 1.3 to double-check if the risk estimate we provide is consistent with the expected return of 0.16%. CSL has a performance score of 9 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.42, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, CSL's returns are expected to increase less than the market. However, during the bear market, the loss of holding CSL is expected to be smaller as well. CSL currently shows a risk of 1.38%. Please confirm CSL treynor ratio, as well as the relationship between the expected short fall and day median price , to decide if CSL will be following its price patterns.
Auto-correlation | 0.30 |
Below average predictability
CSL has below average predictability. Overlapping area represents the amount of predictability between CSL time series from 10th of November 2025 to 25th of December 2025 and 25th of December 2025 to 8th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CSL price movement. The serial correlation of 0.3 indicates that nearly 30.0% of current CSL price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.3 | |
| Spearman Rank Test | 0.5 | |
| Residual Average | 0.0 | |
| Price Variance | 6.03 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, CSL reported net income of 2.25 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Biotechnology industry. The net income for all United States stocks is significantly lower than that of the firm.
CSL Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CSL's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of CSL could also be used in its relative valuation, which is a method of valuing CSL by comparing valuation metrics of similar companies.CSL is currently under evaluation in net income category among its peers.
CSL Fundamentals
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0613 | |||
| Profit Margin | 0.18 % | |||
| Operating Margin | 0.25 % | |||
| Current Valuation | 96.65 B | |||
| Shares Outstanding | 964.43 M | |||
| Shares Owned By Institutions | 0.07 % | |||
| Price To Earning | 34.45 X | |||
| Price To Book | 6.77 X | |||
| Price To Sales | 9.04 X | |||
| Revenue | 10.49 B | |||
| Gross Profit | 5.73 B | |||
| EBITDA | 3.46 B | |||
| Net Income | 2.25 B | |||
| Cash And Equivalents | 10.44 B | |||
| Cash Per Share | 10.83 X | |||
| Total Debt | 3.86 B | |||
| Debt To Equity | 0.66 % | |||
| Current Ratio | 2.32 X | |||
| Book Value Per Share | 16.27 X | |||
| Cash Flow From Operations | 2.63 B | |||
| Earnings Per Share | 2.40 X | |||
| Number Of Employees | 30 K | |||
| Beta | 0.19 | |||
| Market Capitalization | 103.45 B | |||
| Total Asset | 28.35 B | |||
| Retained Earnings | 6.59 B | |||
| Working Capital | 2.44 B | |||
| Current Asset | 3.82 B | |||
| Current Liabilities | 1.37 B | |||
| Z Score | 15.6 | |||
| Annual Yield | 0.01 % | |||
| Five Year Return | 1.08 % | |||
| Net Asset | 28.35 B | |||
| Last Dividend Paid | 2.22 |
About CSL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CSL's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CSL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CSL based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CSL Pink Sheet Analysis
When running CSL's price analysis, check to measure CSL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CSL is operating at the current time. Most of CSL's value examination focuses on studying past and present price action to predict the probability of CSL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CSL's price. Additionally, you may evaluate how the addition of CSL to your portfolios can decrease your overall portfolio volatility.